BBIO insider sale via option exercise on 08/05/2025 — 17,167 shares

Rhea-AI Filing Summary

Form 144 summary for BridgeBio Pharma, Inc. (BBIO)

This Form 144 reports an insider sale on 08/05/2025: 17,167 common shares sold through Morgan Stanley Smith Barney LLC (Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004) with an aggregate market value of $841,183.00. The filing lists 189,880,720 shares outstanding. The securities were acquired and paid for on 08/05/2025 via a stock option exercise from the issuer with cash payment. The filer reports "Nothing to Report" for securities sold in the past three months.

Note: Several filer and issuer contact fields in the form are blank in the provided text.

Insights

Securities Analyst

TL;DR: Small insider sale via option exercise on 08/05/2025; transaction size is immaterial versus total outstanding shares.

The filing documents a single transaction: 17,167 common shares sold through Morgan Stanley Smith Barney for an aggregate $841,183.00. Acquisition and payment occurred the same day by stock option exercise and cash. No other insider sales were reported in the prior three months. Impact to capitalization or control is minimal given the reported outstanding share count of 189,880,720. Investors should note the transaction type (option exercise) when interpreting insider intent, but the filing contains no additional material disclosures.

Corporate Governance Expert

TL;DR: Disclosure complies with Rule 144 mechanics; no red flags in the notice itself.

The Form 144 provides required broker, share count, aggregate value, and acquisition details, and includes the issuer-outstanding share figure. The filer affirms no undisclosed material adverse information. Several administrative fields (filer CIK, issuer name/address) appear blank in the extracted text; ensure complete records are filed with the SEC. Overall governance implications are neutral based on this single, routine option-exercise sale.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	17167	841183.00	189880720	08/05/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/05/2025	Stock Option Exercise	Issuer			17167	08/05/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did BridgeBio (BBIO) report on Form 144 dated 08/05/2025?

The Form 144 reports sale of 17,167 common shares on 08/05/2025 via Morgan Stanley Smith Barney LLC with aggregate value $841,183.00.

How were the BBIO shares acquired and paid for according to the filing?

The securities were acquired by stock option exercise from the issuer on 08/05/2025 and payment was made in cash on the same date.

How many BBIO shares were outstanding as reported in the Form 144?

The filing lists 189,880,720 shares outstanding.

Were there any other insider sales by the filer in the prior three months?

The Form 144 states "Nothing to Report" for securities sold during the past three months.

Which broker handled the transaction in the BBIO Form 144?

The broker named is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.